Nanomole-scale high-throughput chemistry for the synthesis of complex molecules

Breaking through the milligram floor When chemists synthesize compounds, the threshold for success is at least a milligram of product. This has been true for decades—even though biochemical assays have long since descended into microgram territory—and results in part from the constraints of characterization methods. Buitrago Santanilla et al. present an automated dosing and characterization protocol for optimizing chemical reaction conditions on the microgram scale. This allowed them to screen numerous base and ligand combinations for catalytic C-N bond-forming reactions between complex pairs of compounds, in short supply, that resisted standard coupling conditions. Science, this issue p. 49 Automated technology enables chemical reaction optimization using micrograms of material. At the forefront of new synthetic endeavors, such as drug discovery or natural product synthesis, large quantities of material are rarely available and timelines are tight. A miniaturized automation platform enabling high-throughput experimentation for synthetic route scouting to identify conditions for preparative reaction scale-up would be a transformative advance. Because automated, miniaturized chemistry is difficult to carry out in the presence of solids or volatile organic solvents, most of the synthetic “toolkit” cannot be readily miniaturized. Using palladium-catalyzed cross-coupling reactions as a test case, we developed automation-friendly reactions to run in dimethyl sulfoxide at room temperature. This advance enabled us to couple the robotics used in biotechnology with emerging mass spectrometry–based high-throughput analysis techniques. More than 1500 chemistry experiments were carried out in less than a day, using as little as 0.02 milligrams of material per reaction.

[1]  Frank Glorius,et al.  Contemporary screening approaches to reaction discovery and development. , 2014, Nature chemistry.

[2]  Mark Peplow,et al.  Organic synthesis: The robo-chemist , 2014, Nature.

[3]  Petra Schneider,et al.  Accessing new chemical entities through microfluidic systems. , 2014, Angewandte Chemie.

[4]  K. Houk,et al.  Non-Directed Allylic C-H Acetoxylation in the Presence of Lewis Basic Heterocycles. , 2014, Chemical science.

[5]  Shane W. Krska,et al.  Late-stage functionalization of biologically active heterocycles through photoredox catalysis. , 2014, Angewandte Chemie.

[6]  Christopher J. Welch,et al.  9.02 High-Throughput Analysis for High-Throughput Experimentation in Organic Chemistry , 2014 .

[7]  P. Chirik,et al.  Cobalt Precursors for High-Throughput Discovery of Base Metal Asymmetric Alkene Hydrogenation Catalysts , 2013, Science.

[8]  Shane W. Krska,et al.  High-throughput optimization of Ir-catalyzed C-H borylation: a tutorial for practical applications. , 2013, Journal of the American Chemical Society.

[9]  Paul M. Murray,et al.  Beyond the Numbers: Charting Chemical Reaction Space , 2013 .

[10]  S. Buchwald,et al.  Design and Preparation of New Palladium Precatalysts for C-C and C-N Cross-Coupling Reactions. , 2012, Chemical science.

[11]  Simon Berritt,et al.  Scientist-Led High-Throughput Experimentation (HTE) and Its Utility in Academia and Industry , 2013 .

[12]  Suresh Babu,et al.  Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor that Affords Robust CNS Aβ Reduction. , 2012, ACS medicinal chemistry letters.

[13]  Kendall N Houk,et al.  Rapid catalyst identification for the synthesis of the pyrimidinone core of HIV integrase inhibitors. , 2012, Angewandte Chemie.

[14]  M. Hann,et al.  Finding the sweet spot: the role of nature and nurture in medicinal chemistry , 2012, Nature Reviews Drug Discovery.

[15]  Y. Pommier,et al.  Bicyclic Hydroxy‐1H‐pyrrolopyridine‐trione Containing HIV‐1 Integrase Inhibitors , 2012, Chemical biology & drug design.

[16]  Channa K. Hattotuwagama,et al.  Lead-oriented synthesis: a new opportunity for synthetic chemistry. , 2012, Angewandte Chemie.

[17]  P. Váchal,et al.  High-throughput purification platform in support of drug discovery. , 2012, ACS combinatorial science.

[18]  Christopher K Prier,et al.  Discovery of an α-Amino C–H Arylation Reaction Using the Strategy of Accelerated Serendipity , 2011, Science.

[19]  M. Sigman,et al.  Three-Dimensional Correlation of Steric and Electronic Free Energy Relationships Guides Asymmetric Propargylation , 2011, Science.

[20]  John F. Hartwig,et al.  A Simple, Multidimensional Approach to High-Throughput Discovery of Catalytic Reactions , 2011, Science.

[21]  E. Corley,et al.  Convergent Kilo-Scale Synthesis of a Potent Renin Inhibitor for the Treatment of Hypertension , 2011 .

[22]  Allan M Jordan,et al.  The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. , 2011, Journal of medicinal chemistry.

[23]  Deryn E. Fogg,et al.  The Future, Faster: Roles for High-Throughput Experimentation in Accelerating Discovery in Organometallic Chemistry and Catalysis† , 2011 .

[24]  S. Buchwald,et al.  Dialkylbiaryl Phosphines in Pd-Catalyzed Amination: A User's Guide. , 2010, Chemical science.

[25]  W. Tong,et al.  Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry. , 2010, Analytical chemistry.

[26]  Simon J F Macdonald,et al.  Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries). , 2010, Angewandte Chemie.

[27]  Christopher J. Welch,et al.  MISER chromatography (multiple injections in a single experimental run): the chromatogram is the graph , 2010 .

[28]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[29]  T. Ishikawa Superbases for Organic Synthesis: Guanidines, Amidines, Phosphazenes and Related Organocatalysts , 2009 .

[30]  A. Kojima,et al.  Synthesis and structure-activity relationship studies of highly potent novel oxazolidinone antibacterials. , 2008, Journal of medicinal chemistry.

[31]  S. Denmark,et al.  Vinylation of aromatic halides using inexpensive organosilicon reagents. Illustration of design of experiment protocols. , 2008, Journal of the American Chemical Society.

[32]  M. Kozlowski,et al.  A priori theoretical prediction of selectivity in asymmetric catalysis: design of chiral catalysts by using quantum molecular interaction fields. , 2006, Angewandte Chemie.

[33]  S. Buchwald,et al.  Expedited palladium-catalyzed amination of aryl nonaflates through the use of microwave-irradiation and soluble organic amine bases. , 2006, The Journal of organic chemistry.

[34]  M. Havranek,et al.  New fluorogenic probes for oxygen and carbene transfer: a sensitive assay for single bead-supported catalysts. , 2001, Journal of the American Chemical Society.

[35]  D. Riendeau,et al.  Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors. , 1999, Bioorganic & medicinal chemistry letters.

[36]  Robert B. Nachbar,et al.  The design, binding affinity prediction and synthesis of macrocyclic angiotensin II AT1 and AT2 receptor antagonists , 1996 .